Modeling HPV and Cervical Cancer in the U.S.
Author Information
Author(s): Jeremy D Goldhaber-Fiebert, Natasha K Stout, Jesse Ortendahl, Karen M Kuntz, Sue J Goldie, Joshua A Salomon
Primary Institution: Harvard School of Public Health
Hypothesis
What are the expected health outcomes associated with different cervical cancer prevention strategies in the U.S.?
Conclusion
The study provides a comprehensive model that quantifies the uncertainty in health outcomes related to cervical cancer prevention strategies.
Supporting Evidence
- Approximately 200 good-fitting parameter sets were identified from 1,000,000 simulated sets.
- Modeled screening outcomes were externally consistent with results from multiple independent data sources.
- The expected reductions in lifetime risk of cancer with annual or biennial screening were 76% and 69%, respectively.
- The reduction from vaccination alone was 75%, reflecting considerable parameter uncertainty.
- The uncertainty surrounding the model-predicted reduction in cervical cancer incidence narrowed when vaccination was combined with every-5-year screening.
Takeaway
This study created a computer model to help understand how different ways to prevent cervical cancer can work together to keep women healthy.
Methodology
A stochastic microsimulation model was developed to simulate the natural history of cervical cancer and calibrate it against epidemiologic data.
Potential Biases
The model's assumptions about the natural history of HPV and cervical cancer may introduce bias.
Limitations
The model relies on data from heterogeneous sources, which may not be entirely consistent, and the calibration may lead to overfitting.
Participant Demographics
The model simulates a population of women starting from age 9 and considers various HPV types and health states.
Statistical Information
Confidence Interval
69–82%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website